ArticleBone marrow transplantation2018

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.

Katie S Gatwood et al.PubMed ↗Publisher ↗

No numbers read from the abstract.